Coastlands Capital LP Acquires ADIL Shares

Coastlands Capital LP, a ten percent owner of ADIAL PHARMACEUTICALS, INC. (ADIL), reported two recent transactions. On July 14, 2026, Coastlands Capital LP acquired 2,000 shares of common stock at $2.65 per share, bringing their total holdings to 387,075 shares. Two days later, on July 16, 2026, an additional 1,233 shares were acquired at $2.75 per share, increasing their total holdings to 388,308 shares. These transactions were executed indirectly by Coastlands Capital LP, with Matthew Perry identified as the control person for the entities involved. The filing was made on Form 4, indicating a change in beneficial ownership.